•
Dec 31, 2018

Jazz Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$476M
Previous year: $436M
+9.2%
EPS
$3.64
Previous year: $2.95
+23.4%
Gross Profit
$450M
Previous year: $411M
+9.5%
Cash and Equivalents
$310M
Previous year: $386M
-19.8%
Free Cash Flow
$204M
Total Assets
$5.2B
Previous year: $5.12B
+1.6%

Jazz Pharmaceuticals

Jazz Pharmaceuticals

Jazz Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income